Standard Biotools Agrees To Sell Microfluidics Business To ARCHIMED
(RTTNews) - On Monday, Standard BioTools Inc. (NASDAQ: LAB) announced that it has signed a definitive agreement to sell its Microfluidics business to ARCHIMED, an investment firm focused on the healthcare industry.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.